M.E.I. Schipper
Impact in
- Hepatology top 5%
- Epidemiology top 2%
- Cervical Cancer and HPV Research
- Infective Endocarditis Diagnosis and Management
- Liver Disease Diagnosis and Treatment
Papers in
- Co-authors
- Bas Oldenburg (15 shared papers)Peter D. Siersema (18 shared papers)Karel J. van Erpecum (6 shared papers)Antonio Moschetta (2 shared papers)Raffaella Maria Gadaleta (2 shared papers)Saskia W. C. van Mil (2 shared papers)Inne H.M. Borel Rinkes (8 shared papers)Melvin Samsom (9 shared papers)
- Journals
- The Journal of Heart and Lung Transplantation (4 papers)Gut (4 papers)PLoS ONE (3 papers)Inflammatory Bowel Diseases (3 papers)EuroIntervention (3 papers)
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
M.E.I. Schipper
87 papers receiving 3.6k citations
M.E.I. Schipper's Hit Papers
Peers
Comparison fields: 5 of 108
- Hepatology 230
- Epidemiology 980
- Gastroenterology 155
- Cardiology and Cardiovascular Medicine 568
- Oncology 656
Countries citing papers authored by M.E.I. Schipper
This map shows the geographic impact of M.E.I. Schipper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.E.I. Schipper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.E.I. Schipper more than expected).
Fields of papers citing papers by M.E.I. Schipper
This network shows the impact of papers produced by M.E.I. Schipper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.E.I. Schipper. The network helps show where M.E.I. Schipper may publish in the future.
Co-authors
The 25 scholars most cited alongside M.E.I. Schipper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease Hit paper breakdown → | 2011 | 672 |
| 2 | 1993 | 225 | |
| 3 | 2013 | 178 | |
| 4 | 2016 | 168 | |
| 5 | 2008 | 158 | |
| 6 | 2015 | 128 | |
| 7 | 2009 | 116 | |
| 8 | 1994 | 100 | |
| 9 | 2011 | 98 | |
| 10 | 2013 | 97 | |
| 11 | 2005 | 85 | |
| 12 | 2014 | 83 | |
| 13 | 2002 | 79 | |
| 14 | 2003 | 76 | |
| 15 | 2007 | 61 | |
| 16 | 2002 | 60 | |
| 17 | 2009 | 56 | |
| 18 | 2004 | 53 | |
| 19 | 2010 | 47 | |
| 20 | 2009 | 44 |
About M.E.I. Schipper
M.E.I. Schipper is a scholar working on Surgery, Oncology, Genetics, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 88 papers that have together received 3.7k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (8 papers), Cardiac Valve Diseases and Treatments (6 papers), Esophageal Cancer Research and Treatment (6 papers), Helicobacter pylori-related gastroenterology studies (5 papers), Mechanical Circulatory Support Devices (5 papers), Colorectal Cancer Surgical Treatments (5 papers), Colorectal Cancer Screening and Detection (5 papers) and Genetic factors in colorectal cancer (5 papers). The work is most often cited by research in Hepatology (230 citations), Epidemiology (980 citations), Gastroenterology (155 citations), Cardiology and Cardiovascular Medicine (568 citations) and Oncology (656 citations). M.E.I. Schipper has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Bas Oldenburg, Peter D. Siersema, Karel J. van Erpecum, Antonio Moschetta, Raffaella Maria Gadaleta, Saskia W. C. van Mil, Inne H.M. Borel Rinkes, Melvin Samsom, Silvio Danese and Ellen C.L. Willemsen. Their work appears in journals such as The Journal of Heart and Lung Transplantation, Gut, PLoS ONE, Inflammatory Bowel Diseases and EuroIntervention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.